Issue 87, 2020

pH-Responsive dopamine-based nanoparticles assembled via Schiff base bonds for synergistic anticancer therapy

Abstract

The dynamic Schiff base bond is exploited to construct monodisperse dopamine-based nanoparticles with autofluorescence and pH-sensitivity. This allows facile monitoring and pH-responsive drug release in the acidic tumor microenvironment. Anticancer drugs doxorubicin and a photosensitizer chlorin e6 are further loaded into the nanoparticles and synergistic anticancer efficacy is achieved.

Graphical abstract: pH-Responsive dopamine-based nanoparticles assembled via Schiff base bonds for synergistic anticancer therapy

Supplementary files

Article information

Article type
Communication
Submitted
06 Jul 2020
Accepted
25 Sep 2020
First published
26 Sep 2020

Chem. Commun., 2020,56, 13347-13350

pH-Responsive dopamine-based nanoparticles assembled via Schiff base bonds for synergistic anticancer therapy

H. Li, Y. Zhao, Y. Jia, G. Chen, J. Peng and J. Li, Chem. Commun., 2020, 56, 13347 DOI: 10.1039/D0CC04656F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements